Purity Specifications, Storage and Distribution for Medications Development

This solicitation seeks offers to provide purity specifications, storage, and distribution services for medication development to the National Institute on Drug Abuse and other NIH institutes. Offerors must propose to serve as a centralized repository to receive, analyze, and store compounds from domestic and foreign submitters for evaluation as potential treatment agents, standards, and screening agents. The base period of performance is July 2022 through July 2023, with four optional one-year extensions. Proposals must be submitted by February 11, 2022 and will be evaluated based on technical qualifications, past performance, and pricing.

There is no set-aside designation. The primary NAICS code is 541715 and PSC code is R425. The selected offeror must comply with DEA registration requirements, handle toxic substances, and the place of performance will be the offeror's facility. Key details include the solicitation includes pricing terms for the base period and optional quantities, some compounds may be neurotoxins, and the selected contractor must have the capability to receive, analyze, and store compounds within required timeframes and purity specifications.